MAGNESIUM BICARBONATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	2CHO3.Mg
Molecular Weight	146.3387
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Mg++].OC([O-])=O.OC([O-])=O

InChI

InChIKey=QWDJLDTYWNBUKE-UHFFFAOYSA-L

InChI=1S/2CH2O3.Mg/c2*2-1(3)4;/h2*(H2,2,3,4);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula	CH2O3
Molecular Weight	62.0248
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Mg
Molecular Weight	24.305
Charge	2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.dancingwithwater.com/articles/magnesium-bicarbonate-water-the-importance-of-bicarbonates-and-magnesium/https://www.ncbi.nlm.nih.gov/pubmed/8770963
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/9070556

Magnesite (magnesium carbonate) is a non-toxic mineral. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients. It prevents vascular calcification in these patients. Many patients with heavily symptomatic Mitral valve prolapse syndrome have low serum magnesium, and supplementation of this ion by means of magnesium carbonate leads to improvement in most symptoms.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
magnesium ion homeostasis 70 Target ID: GO:0010960 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9070556	Modulator 846
Magnesium-bicarbonate ATPase 2 Target ID: Magnesium-bicarbonate ATPase Sources: https://www.ncbi.nlm.nih.gov/pubmed/162573	Activator 1447

Conditions

Condition	Modality	Highest Phase	Product
Mitral valve prolapse syndrome 2 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9070556	Palliative	Phase II 1147	Unknown Approved Use Unknown
Paroxysmal supraventricular tachycardia 7 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7483616	Preventing	Phase II 1147	Unknown Approved Use Unknown
Hyperphosphatemia 30 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21812357	Primary	Phase II 1147	Unknown Approved Use Unknown
Dyslipidemia 34 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20579398	Primary	Not Provided 511	Unique Water Approved Use Unknown

PubMed

Title	Date	PubMed
Hypolipidemic activity of a natural mineral water rich in calcium, magnesium, and bicarbonate in hyperlipidemic adults.	2014	24754016
[Clinical aspects of antimicrobial therapy used in patients with urogenital infections].	2012	23479999
[The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].	2011	21812357
A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenopausal women.	2010-06-28	20579398
Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation.	1997-03-15	9070556
[Magnesium or proajmaline (neogilurytmal) in treatment of recurrences of paroxysmal supraventricular tachyarrhythmias?].	1994-10	7483616

Patents

Sample Use Guides

In Vivo Use Guide

6 to 8 glasses of magnesium bicarbonate water per day (125mg/L of magnesium).

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:37:57 GMT 2025` Edited by `admin` on `Mon Mar 31 19:37:57 GMT 2025`
Record UNII	19E9A0647O
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

KRUSE'S FLUID MAGNESIA

Preferred Name

English

MAGNESIUM BICARBONATE

Systematic Name

English

MAGNESIUM HYDROCARBONATE

Common Name

English

Magnesium bicarbonate [WHO-DD]

Common Name

English

Code System Code Type Description

PUBCHEM

102204